Detail
LncRNA Name | MALAT1 |
Synonyms | MALAT1, HCN, LINC00047, NCRNA00047, NEAT2, PRO2853, PRO1073, MALAT-1, mascRNA |
Region | GRCh38_11:65497688-65506516 Sequence |
Ensembl | ENSG00000251562 |
RefSeq | NR_002819 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✔ |
Methylation | ✘ |
Cancer Name | prostate cancer |
ICD-0-3 | C61.9 |
Methods | microarray, qPCR etc. |
Sample | cell lines (UMR-106 and PC3) |
Expression Pattern | up-regulated |
Function Description | The qPCR data showed a ~6-fold increase in MALAT1 expression in PC3 cells co-cultured with UMR osteoblasts compared to PC3 monocultures. Treatment with recombinant SOST resulted in ~5.6-fold reduction in MALAT1 expression, suggesting that Sost in the tumor microenvironment may have an inhibitory effect on MALAT1 and down-regulation of Sost in the bone microenvironment may enhance MALAT1 expression in prostate cancer. |
Pubmed ID | 27600237 |
Year | 2016 |
Title | Cancer-Osteoblast Interaction Reduces Sost Expression in Osteoblasts and Up-Regulates lncRNA MALAT1 in Prostate Cancer. |
External Links |
Links for MALAT1 | GenBank HGNC lncrnadb Noncode |
Links for prostate cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.